Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation
- 1 October 2000
- journal article
- research article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 62 (4) , 367-384
- https://doi.org/10.1016/s0090-6980(00)00089-7
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Ultraviolet B radiation-induced production of interleukin 1α and interleukin 6 in a human squamous carcinoma cell line is wavelength-dependent and can be inhibited by pharmacological agentsBritish Journal of Dermatology, 1998
- Induction of Cyclooxygenase-2 Expression by Peroxisome Proliferators and Non-tetradecanoylphorbol 12,13-Myristate-type Tumor Promoters in Immortalized Mouse Liver CellsPublished by Elsevier ,1997
- Prostaglandin synthase 2Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- The role of nonsteroidal anti-inflammatory drugs in colorectal cancer preventionEuropean Journal Of Cancer, 1995
- Characterization of sunburn cells after exposure to ultraviolet lightPhotodermatology, Photoimmunology & Photomedicine, 1995
- Analysis of the Mechanism of Ultraviolet (UV) B Radiation – Induced Prostaglandin E2 Synthesis by Human Epidermoid Carcinoma CellsJournal of Investigative Dermatology, 1993
- Activation of Neutrophil Membrane-Associated Oxidative Metabolism by Ultraviolet RadiationJournal of Investigative Dermatology, 1993
- Xenobiotic metabolism by prostaglandin H synthasePharmacology & Therapeutics, 1992
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Prostaglandins in Peptic Ulcer DiseaseDrugs, 1986